DEUTSCHE BANK AG\ - CORREVIO PHARMA CORP ownership

CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 23 filers reported holding CORREVIO PHARMA CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of CORREVIO PHARMA CORP
ValueSharesWeighting
Q4 2018$11,000
-93.2%
4,800
-88.1%
0.00%
Q3 2018$161,000
+30.9%
40,200
+23.3%
0.00%
Q2 2018$123,00032,6000.00%
Other shareholders
CORREVIO PHARMA CORP shareholders Q2 2018
NameSharesValueWeighting ↓
SUMMER ROAD LLC 4,325,000$8,650,00042.79%
Tamarack Advisers, LP 4,500,000$9,000,0002.34%
Stonepine Capital Management, LLC 509,356$1,019,0000.99%
CLOUGH CAPITAL PARTNERS L P 2,057,124$4,114,0000.34%
Worth Venture Partners, LLC 101,364$203,0000.12%
ESSEX INVESTMENT MANAGEMENT CO LLC 349,148$698,0000.10%
Rock Springs Capital Management LP 1,200,000$2,400,0000.10%
WESTFIELD CAPITAL MANAGEMENT CO LP 4,876,455$9,753,0000.08%
ARS Investment Partners, LLC 215,718$431,0000.08%
Perceptive Advisors 1,000,000$2,000,0000.05%
View complete list of CORREVIO PHARMA CORP shareholders